ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,620.88
      0.21%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. Oncotelic Therapeutics Inc (QB) (OTLC)

      7. Oncotelic Therapeutics Inc (QB) (OTLC) News

      OTLC

      Oncotelic Therapeutics (QB) (OTLC)

      Oncotelic Therapeutics Inc (QB)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:OTLC
      DateTimeSourceHeadlineSymbolCompany
      02/02/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
      10/30/20239:00AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
      08/23/202310:30AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
      08/18/20235:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OTLCOncotelic Therapeutics Inc (QB)
      07/13/20239:25AMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
      07/13/20239:15AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
      06/30/20239:26AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      06/30/20239:25AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
      06/20/202312:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      06/16/202312:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      05/31/20239:39AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      05/19/20234:45PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      05/02/20235:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      04/20/20236:04AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      04/14/20235:02PMEdgar (US Regulatory)Annual Report (10-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      04/03/20236:04AMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      03/02/20239:01AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      12/07/20228:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      11/25/20229:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      11/18/20225:02PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      11/14/20222:25PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      09/28/20229:16AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      08/29/20229:16AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      08/22/20228:32AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      08/15/20222:34PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      07/15/20227:04AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      06/22/20228:47AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      05/23/20226:22AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      05/11/20225:11PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:OTLCOncotelic Therapeutics Inc (QB)
      04/15/20224:28PMEdgar (US Regulatory)Annual Report (10-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
       Showing the most relevant articles for your search:USOTC:OTLC